Ratings on (VMED) (VELT) (CA) (LCAPA) (JWN) Reiterated

Ratings on shares of Virgin Media (NASDAQ:VMED), Velti (NASDAQ:VELT), CA Tech (NASDAQ:CA), Liberty Media Capital (NASDAQ:LCAPA) and Nordstrom (NYSE:JWN) reiterated by analysts.

Wunderlich reiterated an "Buy" rating on Virgin Media (VMED). They raised their price target on the company from $32 to $37.

Needham reiterated a "Sector Perform" rating on Velti (VELT). They raised their price target on the company from $17 to $21.

Needham reiterated a "Buy" rating on CA Tech (CA). They raised their price target on the company from $27 to $29.

Wunderlich reiterated a "Buy" rating on Liberty Media Capital (LCAPA). They raised their price target on the company from $85 to $95.

FBR Capital reiterated a "Market Perform" rating on Nordstrom (JWN). They raised their price target on the company from $48 to $50.

Price Targets on (VELT) (VRNM) (PCP) Updated

Price targets on shares of Velti (NASDAQ: VELT), Verenium (NASDAQ: VRNM) and Precision Castparts (NYSE: PCP) were updated by analysts.

Wedbush raised their price target on Precision Castparts (PCP) from $165.00 to $170.00. They have an “outperform” rating on the company.

Jefferies (NYSE:JEF) raised their price target on Velti (VELT) from $18.50 to $23.00. They have a “buy” rating on the company.

Jefferies cut their price target on Verenium (VRNM) from $3.30 to $2.95. They have a “hold” rating on the company.

Price Targets on (PCP) (QCOR) (VELT) (VMED) Updated

Price targets on Precision Castparts (NYSE: PCP), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Velti (NASDAQ: VELT) and Virgin Media (NASDAQ: VMED) were updated by analysts.

Stifel Nicolaus raised their price target on Precision Castparts (PCP) from $175.00 to $180.00.

Oppenheimer raised their price target on Questcor Pharmaceuticals, Inc. (QCOR) to $27.00.

Needham & Company raised their price target on Velti (VELT) from $17.00 to $21.00. They have a “buy” rating on the company.

Wunderlich raised their price target on Virgin Media (VMED) from $32.00 to $37.00. They have a “buy” rating on the company.